Factors of imatinib resistance in chronic myeloid leukemia

被引：0
|
作者：
Kajtar, B. [1 ]
Alpar, D. [1 ]
Toth, J. [1 ]
Laszlo, R. [1 ]
Jakso, R. [1 ]
Kereskai, L. [1 ]
Nagy, Z. [1 ]
Pajor, L. [1 ]
机构：
[1] Univ Pecs, Dept Pathol, H-7622 Pecs, Hungary
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70053-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [1] Strategies for overcoming imatinib resistance in chronic myeloid leukemia
    Kujawski, Lisa
    Talpaz, Moshe
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2310 - 2322
  • [2] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Elias Jabbour
    Jorge Cortes
    Hagop Kantarjian
    Targeted Oncology, 2009, 4 : 3 - 10
  • [3] Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
    Quintes-Cardama, Alfonso
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    CANCER CONTROL, 2009, 16 (02) : 122 - 131
  • [4] Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance
    Sandoval, C
    Giamelli, J
    Jayabose, S
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 507 - 508
  • [5] Imatinib resistance in chronic myeloid leukemia due to a rare mutation
    Balasubramanian, Priyavadhana
    Chopra, Anita
    Verma, Deepak
    Singh, Indresh K.
    Kumar, Akash
    Sharma, Atul
    Kumar, Rajive
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1750 - 1752
  • [6] Chronic myeloid leukemia. Genetic mechanisms of resistance to Imatinib
    Bengio, Raquel M.
    Gargallo, Patricia
    Barreyro, Paula
    Bitton, Roberto
    Larripa, Irene
    MEDICINA-BUENOS AIRES, 2007, 67 : 71 - 74
  • [7] New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance
    Kantarjian, Hagop M.
    Talpaz, Moshe
    Giles, Francis
    O'Brien, Susan
    Cortes, Jorge
    ANNALS OF INTERNAL MEDICINE, 2006, 145 (12) : 913 - 923
  • [8] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    TARGETED ONCOLOGY, 2009, 4 (01) : 3 - 10
  • [9] Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
    Lee, Sung-Eun
    Choi, Soo Young
    Bang, Ju-Hee
    Kim, Soo-Hyun
    Jang, Eun-jung
    Byeun, Ji-Young
    Park, Jin-Eok
    Jeon, Hye-Rim
    Oh, Yun Jeong
    Kim, Hyeoung-Joon
    Kim, Yeo-Kyeoung
    Park, Joon Seong
    Jeong, Seong Hyun
    Kim, Sung-Hyun
    Zang, Dae Young
    Oh, Sukjoong
    Koo, Dong Hoe
    Kim, Hawk
    Do, Young Rok
    Kwak, Jae-Yong
    Kim, Jeong-A
    Kim, Dae-Young
    Mun, Yeung-Chul
    Mauro, Michael J.
    Kim, Dong-Wook
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (06) : 449 - 454
  • [10] Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells
    Baran, Yusuf
    Ural, Ali Ugur
    Gunduz, Ufuk
    HEMATOLOGY, 2007, 12 (06) : 497 - 503
12345